Objectives
Following the encouraging result of several registries and trials, very limited data exist on TAVI in the setting of a preexisting mitral prosthesis regarding the technique, potential complications, and outcomes. Therefore, we aimed to report our single centre experience with the implantation of the self-expandable CoreValve (Medtronic Inc., Minneapolis MN, USA) bioprostheticaortic valve in six patients with severe aortic stenosis.
Methods
This retrospective, observational study involved the period between February 2013 and December 2015, and all patients had previous mitral valve surgery in whom transfemoral TAVI has been performed at our center.
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)